Is DQ a Buy or a Sell? The Bull and Bear Case (2026)

Last updated October 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Daqo New Energy (DQ) rests on Polysilicon prices and the oversupply cycle: Daqo's earnings are geared directly to polysilicon prices, which crashed under Chinese industry overcapacity that ran well above global demand. The bear case rests on the dominant risk is commodity cyclicality: with revenue tied to polysilicon prices, the current oversupply has already driven deeply negative margins (about negative 132% gross margin in the second quarter of 2026) and large losses, and there is no certainty the market rebalances soon. Analysts covering it publish targets from $10.00 to $31.87 against a $10.23 price, so even the professionals disagree by 111% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Daqo New Energy is a Chinese manufacturer of high-purity polysilicon, the foundational material used to produce solar wafers, cells, and modules. It operates large-scale polysilicon plants in China and sells to downstream wafer and cell makers, so its results are driven almost entirely by polysilicon prices, production volumes, and its cash cost per kilogram rather than by any diversified product mix. The company is US-listed as an American Depositary Receipt on the NYSE, while its main operating subsidiary is separately listed in China, so investors in DQ hold an equity interest in a Chinese solar-materials producer through the ADR structure. Because polysilicon is a commodity, Daqo is a price-taker whose margins swing sharply with the supply-demand balance of the global solar industry. The current picture is dominated by a severe oversupply crisis in Chinese polysilicon. Industry capacity has run well ahead of demand, and Daqo's own results show the damage. In the first quarter of 2026 it sold only about 4,500 metric tons while producing about 43,400, and revenue fell to about $27 million. In the second quarter sales recovered to about 15,200 tons and revenue to about $63 million, but the average selling price dropped to about $4.04 per kilogram, below the $4.57 cash cost and the $5.95 total production cost, for a gross margin of about negative 132% and a net loss attributable to shareholders of about $81 million, or $1.20 per ADS against a $0.57 loss expected. Plants ran at roughly 57% of nameplate capacity. The company still reported about $1.92 billion of cash, short-term investments, deposits and bank notes with zero debt, which is central to the argument that it can survive the downturn, though trailing free cash flow was about negative $363 million. China's largest polysilicon producers, including Tongwei, GCL, Xinte, and Daqo, have moved to coordinate on cutting outdated capacity through a joint venture, and regulators have pushed anti-oversupply, or anti-involution, measures. Separately, in June 2026 Daqo announced an investment agreement for a manufacturing base serving AI data center power infrastructure (energy storage, solid-state transformers and circuit breakers), anchored by its affiliate Daqo Group. Whether supply discipline lifts prices is still the central question for the stock, alongside the ADR-specific risks that come with any US-listed Chinese company.

The bull case: what would have to be true for $31.87

The most optimistic published target on DQ is $31.87, +211.5% from the $10.23 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Polysilicon prices and the oversupply cycle

Daqo's earnings are geared directly to polysilicon prices, which crashed under Chinese industry overcapacity that ran well above global demand. The average selling price fell from about $5.96 per kilogram in the first quarter of 2026 to about $4.04 in the second, below Daqo's own cash cost, and the company posted its fourth straight quarterly loss. The entire bull case depends on the cycle turning: if supply is cut and prices recover, a low-cost producer like Daqo would see profitability rebound quickly, while continued oversupply keeps it deeply unprofitable. Analysts expect a loss of about $3.91 per ADS for 2026 and about $2.61 for 2027.

2. Industry consolidation and anti-oversupply measures

China's leading polysilicon producers, including Tongwei, GCL, Xinte, and Daqo, formed a joint venture aimed at retiring outdated capacity, and regulators have pushed anti-involution policies and funding to close low-quality plants. If these efforts genuinely tighten supply, prices could rebalance and well-positioned producers could re-rate. Execution is uncertain, though, since coordinating capacity cuts across many state-linked and private players is difficult and slow, and Daqo itself still guides to 160,000 to 180,000 tons of output for 2026.

3. Low-cost position and balance sheet strength

Daqo is among the lowest-cost polysilicon producers globally, with a reported cash cost of about $4.57 per kilogram in the second quarter of 2026, which matters enormously in a price war because low-cost operators can outlast higher-cost rivals. It also carries about $1.92 billion of liquidity with zero debt, giving it staying power to survive an extended trough. That cash is more than twice the market value of about $709 million, which is why the stock trades at roughly 0.16 times book value even as the company burns through the cycle.

4. Long-term solar demand and a new AI power side bet

The longer-term backdrop is continued global growth in solar installations, which ultimately requires more polysilicon. If demand keeps rising while the industry finally rationalizes excess capacity, the supply-demand balance could tighten in Daqo's favor. This structural tailwind is real but slow-moving. In June 2026 Daqo also signed an investment agreement for a manufacturing base serving AI data center power infrastructure with its affiliate Daqo Group, which has lifted R&D spending; how much capital that absorbs, and whether it generates revenue, is still unclear.

The bear case: what would have to be true for $10.00

The most pessimistic published target is $10.00, -2.2% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Daqo New Energy is worth if the risks below bite instead of the drivers above.

The dominant risk is commodity cyclicality: with revenue tied to polysilicon prices, the current oversupply has already driven deeply negative margins (about negative 132% gross margin in the second quarter of 2026) and large losses, and there is no certainty the market rebalances soon. Losses have also run well beyond expectations, with first- and second-quarter results missing the consensus by wide margins. Industry capacity cuts and anti-oversupply measures may fail, be slow, or be undermined by players restarting idled plants. As a US-listed Chinese ADR, Daqo carries distinct risks: Chinese government policy and regulatory shifts, US-China trade tensions and potential tariffs or sanctions on solar goods, currency exposure, and the ongoing risk of tightened rules on US-listed Chinese companies, including audit and delisting concerns. The ADR structure means investors hold an indirect interest tied to a separately China-listed operating entity, and the cash sits largely inside Chinese entities. Solar-supply-chain scrutiny over forced-labor and origin concerns can also disrupt demand. The new AI power infrastructure investment with an affiliate adds related-party and capital-allocation questions. Even with a strong balance sheet, a prolonged trough could consume cash, and the stock is highly volatile around price data, policy news, and geopolitical headlines.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding DQ already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on DQ

6 analysts cover DQ, with an average target of $19.64 (+92.0% against $10.23) and a split of 5 buy, 1 hold, 1 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the DQ forecast and price target page.

How is DQ valued? (as of October 2026)

Price
$10.23
Market cap
$692.22M
Forward P/E
-3.91
Price / book
0.16
Beta
0.67
52-week range
$10.23 to $36.59

Snapshot for DQ as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Revenue (TTM): ~$556 million; Q2 2026 ~$63 million
  • Net income (TTM): ~-$192 million; Q2 2026 net loss ~$81 million (-$1.20 per ADS vs -$0.57 estimate)
  • Polysilicon pricing (Q2 2026): ~$4.04/kg average selling price vs ~$4.57/kg cash cost
  • Gross margin (Q2 2026): ~-132%
  • Liquidity: ~$1.92 billion in cash, investments, deposits and bank notes; zero debt
  • Market cap: ~$709 million at ~$10.48 per ADS; ~0.16x book value

For a loss-making cyclical, earnings multiples are not meaningful; investors instead watch polysilicon prices, utilization, cash burn, and the cash balance relative to market value. At about $709 million, the market values Daqo at well under half of its reported liquidity, a discount that reflects expected cash burn, the ADR and China structure, and doubts about when prices recover. The October 27, 2026 third-quarter report (consensus loss of about $0.48 per ADS on about $62 million of revenue) will show whether pricing has stabilized.

How do you decide if DQ is a buy?

Rather than asking whether DQ is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold DQ indirectly through an index or sector ETF before adding more.

What would change your mind on DQ

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Polysilicon prices and the oversupply cycle stalls in the reported numbers rather than in the narrative around them.
  • Bear case breaks if: the dominant risk is commodity cyclicality: with revenue tied to polysilicon prices, the current oversupply has already driven deeply negative margins (about negative 132% gross margin in the second quarter of 2026) and large losses, and there is no certainty the market rebalances soon fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the DQ stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about DQ against your real portfolio and see your actual exposure before deciding.

Investing in Daqo New Energy with AI

Connect the broker you already use and ask Walnut's AI how DQ fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is DQ a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Polysilicon prices and the oversupply cycle, with revenue (ttm) at ~$556 million; Q2 2026 ~$63 million. The bear case rests on the dominant risk is commodity cyclicality: with revenue tied to polysilicon prices, the current oversupply has already driven deeply negative margins (about negative 132% gross margin in the second quarter of 2026) and large losses, and there is no certainty the market rebalances soon. Analysts covering it are spread from $10.00 to $31.87, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell DQ?

+

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The dominant risk is commodity cyclicality: with revenue tied to polysilicon prices, the current oversupply has already driven deeply negative margins (about negative 132% gross margin in the second quarter of 2026) and large losses, and there is no certainty the market rebalances soon. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $10.00, -2.2% from the $10.23 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for DQ?

+

Polysilicon prices and the oversupply cycle. Daqo's earnings are geared directly to polysilicon prices, which crashed under Chinese industry overcapacity that ran well above global demand. The most optimistic analyst target on DQ is $31.87, +211.5% from the $10.23 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for DQ?

+

The dominant risk is commodity cyclicality: with revenue tied to polysilicon prices, the current oversupply has already driven deeply negative margins (about negative 132% gross margin in the second quarter of 2026) and large losses, and there is no certainty the market rebalances soon. Losses have also run well beyond expectations, with first- and second-quarter results missing the consensus by wide margins. Industry capacity cuts and anti-oversupply measures may fail, be slow, or be undermined by players restarting idled plants. As a US-listed Chinese ADR, Daqo carries distinct risks: Chinese government policy and regulatory shifts, US-China trade tensions and potential tariffs or sanctions on solar goods, currency exposure, and the ongoing risk of tightened rules on US-listed Chinese companies, including audit and delisting concerns. The ADR structure means investors hold an indirect interest tied to a separately China-listed operating entity, and the cash sits largely inside Chinese entities. Solar-supply-chain scrutiny over forced-labor and origin concerns can also disrupt demand. The new AI power infrastructure investment with an affiliate adds related-party and capital-allocation questions. Even with a strong balance sheet, a prolonged trough could consume cash, and the stock is highly volatile around price data, policy news, and geopolitical headlines. The most pessimistic published target is $10.00, -2.2% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

What does Daqo New Energy do?

+

Daqo New Energy is a Chinese manufacturer of high-purity polysilicon, the foundational material used to produce solar wafers, cells, and modules.

What would have to change for DQ to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Polysilicon prices and the oversupply cycle) stalling in the reported numbers rather than in the narrative, the risk above (the dominant risk is commodity cyclicality: with revenue tied to polysilicon prices, the current oversupply has already driven deeply negative margins (about negative 132% gross margin in the second quarter of 2026) and large losses, and there is no certainty the market rebalances soon) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Is DQ a good stock to buy right now?

+

That depends on your goals, time horizon, and risk tolerance, and this is not investment advice. The bull case is a low-cost producer with about $1.92 billion of liquidity and no debt, trading at well under its cash, that could rebound sharply if Chinese capacity cuts finally rebalance polysilicon prices. The bear case is deep oversupply, selling prices below cash cost, losses that keep exceeding estimates, uncertain industry coordination, and Chinese ADR regulatory and geopolitical risk. It is a high-risk, cyclical turnaround bet, not a steady holding.

What does Daqo New Energy actually do?

+

Daqo makes high-purity polysilicon, the raw material used to produce solar wafers, cells, and panels. It operates large polysilicon plants in China and sells to downstream solar manufacturers. It sits at the very start of the solar supply chain, so its results depend almost entirely on polysilicon prices, production volumes, and its cost per kilogram rather than on finished consumer products.

Why has Daqo been losing money?

+

China's polysilicon industry built far more capacity than global demand needed, triggering a severe price war. In the first quarter of 2026 Daqo sold only about 4,500 tons of the roughly 43,400 it produced, and revenue fell to about $27 million. In the second quarter it sold more, but at about $4.04 per kilogram, below its $4.57 cash cost, so gross margin was about negative 132% and the net loss was about $81 million.

Walnut is informational, not investment advice, and gives no verdict on DQ. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

Guides that feature DQ

DQ is one of the names covered in these guides. Each one puts the stock next to its peers so you can see where it fits rather than judging it alone.

The case for and against similar stocks